MedicQuant ApSAktiv
Økonomiske nøgletal
Nøgletal
2025Balancens sammensætning
Selskabsskat
indkomstår 2024Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk
Regnskabstal2020–2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Balance — aktiver | ||||||
| Likvide beholdninger | 141.616 | 301.995 | 91.214 | 10.341.516 | 6.851.299 | 936.529 |
| Omsætningsaktiver i alt | 231.572 | 310.669 | 191.682 | 10.737.489 | 7.626.496 | 2.260.546 |
| Anlægsaktiver i alt | — | — | 20.000 | 1.136.936 | 3.820.141 | 9.197.312 |
| Aktiver i alt | 231.572 | 310.669 | 211.682 | 11.874.425 | 11.446.637 | 11.457.858 |
| Balance — passiver | ||||||
| Kortfristede gældsforpligtelser | 195.254 | 166.633 | 333.704 | 383.907 | 463.519 | 380.797 |
| Langfristede gældsforpligtelser | — | — | — | — | — | — |
| Gældsforpligtelser i alt | 195.254 | 166.633 | 333.704 | 383.907 | 463.519 | 380.797 |
| Selskabskapital | 45.000 | 56.250 | 56.250 | 90.839 | 90.839 | 90.839 |
| Overført resultat | -8.682 | 66.336 | -199.722 | -2.005.376 | -4.450.032 | -9.342.142 |
| Årets resultat | -8.680 | 75.018 | -266.058 | -934.443 | -501.347 | -741.962 |
| Egenkapital i alt | 36.318 | 144.036 | -122.022 | 11.243.535 | 10.742.188 | 10.000.226 |
| Resultatopgørelse | ||||||
| Omsætning | — | 0 | — | — | — | — |
| Bruttofortjeneste | -103.499 | -76.578 | -91.196 | 1.399 | 1.094.375 | 1.911.164 |
| Resultat af primær drift | -708.987 | -225.624 | — | -657.580 | -1.053.864 | -1.098.767 |
| EBITDA | — | — | — | — | — | -1.083.212 |
| Resultat før skat | -8.680 | 75.018 | -341.100 | -858.143 | -1.055.512 | -1.076.611 |
| Årets resultat | -8.680 | 75.018 | -266.058 | -934.443 | -501.347 | -741.962 |
| Personaleomkostninger | 605.488 | 149.046 | 248.094 | 658.979 | 1.792.821 | 2.994.376 |
| Af- og nedskrivninger | — | — | — | — | — | 15.555 |
| Andre nøgletal | ||||||
| Ansatte | — | — | 2 | 3 | 4 | 7 |
En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.
Om virksomheden
Årsrapport 2025Description of key activities of the companyThe purpose of the company is to develop and manufacture medical devices and reagents for in vitro diagnostic purpose.
Significant changes in the company's activities and financial mattersThe gross profit for the year totals DKK 1.911 thousand against DKK 1.094 thousand last year. Profit or loss from ordinary activities after tax totals DKK -742 thousand against DKK -501 thousand last year. Financial resourcesAs of the balance sheet date, the company does not have sufficient funds to continue the development of its project. During February 2026, Management has however secured in excess of DKK 22 million to support the continued development of the project towards commercialisation. Based on this, management has prepared the financial statements as a going concern.
Uddrag af ledelsesberetningen i den seneste årsrapport.